These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 6862298)

  • 1. Monoclonal antibody therapy: "model" experiments with toxin-conjugated antibodies in mice and rats.
    Thorpe PE; Detre SI; Mason DW; Cumber AJ; Ross WC
    Haematol Blood Transfus; 1983; 28():107-11. PubMed ID: 6862298
    [No Abstract]   [Full Text] [Related]  

  • 2. Adoptive immunotherapy of spontaneous leukemia-lymphoma in AKR mice.
    Bortin MM; Truitt RL; Rose WC; Rimm AA; Saltzstein EC
    Adv Exp Med Biol; 1976; 73 Pt B():331-9. PubMed ID: 793340
    [No Abstract]   [Full Text] [Related]  

  • 3. Immunotherapy of experimental animal tumors with antitumor antibodies conjugated to diphtheria toxin or ricin.
    Moolten F; Zajdel S; Cooperband S
    Ann N Y Acad Sci; 1976; 277(00):690-9. PubMed ID: 187103
    [No Abstract]   [Full Text] [Related]  

  • 4. Inhibitory effect of abrin and ricin on the growth of transplantable murine tumors and of abrin on human cancers in nude mice.
    Fodstad O; Olsnes S; Pihl A
    Cancer Res; 1977 Dec; 37(12):4559-67. PubMed ID: 922739
    [No Abstract]   [Full Text] [Related]  

  • 5. Comparison of two anti-Thy 1.1-abrin A-chain immunotoxins prepared with different cross-linking agents: antitumor effects, in vivo fate, and tumor cell mutants.
    Thorpe PE; Blakey DC; Brown AN; Knowles PP; Knyba RE; Wallace PM; Watson GJ; Wawrzynczak EJ
    J Natl Cancer Inst; 1987 Nov; 79(5):1101-12. PubMed ID: 2890786
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biologicals for cancer treatment: monoclonal antibodies.
    Levy R
    Hosp Pract (Off Ed); 1985 Nov; 20(11):67-74, 77, 80-4 passim. PubMed ID: 3932392
    [No Abstract]   [Full Text] [Related]  

  • 7. Prevention of growth of leukemia cells in mice by monoclonal antibodies directed against Thy 1.1 antigen disulfide linked to two ribosomal inhibitors:pokeweed antiviral protein or ricin A chain.
    Ramakrishnan S; Houston LL
    Cancer Res; 1984 Apr; 44(4):1398-404. PubMed ID: 6142765
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics in the rat of a panel of immunotoxins made with abrin A chain, ricin A chain, gelonin, and momordin.
    Wawrzynczak EJ; Cumber AJ; Henry RV; May J; Newell DR; Parnell GD; Worrell NR; Forrester JA
    Cancer Res; 1990 Dec; 50(23):7519-26. PubMed ID: 2253201
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies on the mechanism of action of abrin-9.2.27 immunotoxin in human melanoma cell lines.
    Godal A; Fodstad O; Pihl A
    Cancer Res; 1987 Dec; 47(23):6243-7. PubMed ID: 2445469
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An immunotoxin composed of monoclonal anti-Thy 1.1 antibody and a ribosome-inactivating protein from Saponaria officinalis: potent antitumor effects in vitro and in vivo.
    Thorpe PE; Brown AN; Bremner JA; Foxwell BM; Stirpe F
    J Natl Cancer Inst; 1985 Jul; 75(1):151-9. PubMed ID: 3859688
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug-mediated changes of tumour cell immunogenicity and antigenicity.
    Puccetti P; Romani L; Taramelli D; Bonmassar E; Fioretti MC
    Int J Tissue React; 1982; 4(3):189-99. PubMed ID: 6183194
    [No Abstract]   [Full Text] [Related]  

  • 12. [Studies on toxic proteins of seeds of Abrus precatorius (author's transl)].
    Tung TC
    Taiwan Yi Xue Hui Za Zhi; 1978 Sep; 77(9):699-705. PubMed ID: 281455
    [No Abstract]   [Full Text] [Related]  

  • 13. Antitumor effects of abrin and ricin used singly and in combination with cisplatin.
    Walker EM; Gale GR; Glassman AB; Atkins LM; Bennett CE; Burgis JT
    Ann Clin Lab Sci; 1984; 14(1):10-20. PubMed ID: 6538076
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Derivatives of anti-idiotype antibodies in the treatment of B-cell lymphoma.
    Glennie MJ; Stevenson GT
    Adv Exp Med Biol; 1985; 186():843-53. PubMed ID: 3876727
    [No Abstract]   [Full Text] [Related]  

  • 15. Treatment of micrometastases from Lewis lung carcinoma with abrin and cyclophosphamide, given singly and in combination.
    Gundersen S; Fodstad O
    Int J Cancer; 1979 Apr; 23(4):530-5. PubMed ID: 437927
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Generation of lymphokine-activated killer cells in strain 2 guinea pigs and their use in the therapy of L2C, an acute B-cell leukemia.
    Gregg EO; Gregg IC; Green I
    Cancer Res; 1987 Feb; 47(3):723-9. PubMed ID: 3492265
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of ricin and abrin on survival of L1210 leukemic mice and on leukemic and normal bone-marrow cells.
    Fodstad O; Pihl A
    Int J Cancer; 1978 Nov; 22(5):558-63. PubMed ID: 721316
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytotoxicity acquired by conjugation of an anti-Thy1.1 monoclonal antibody and the ribosome-inactivating protein, gelonin.
    Thorpe PE; Brown AN; Ross WC; Cumber AJ; Detre SI; Edwards DC; Davies AJ; Stirpe F
    Eur J Biochem; 1981 Jun; 116(3):447-54. PubMed ID: 6790277
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibitory effects of four isoabrins on the growth of sarcoma 180 cells.
    Lin JY; Lee TC; Tung TC
    Cancer Res; 1982 Jan; 42(1):276-9. PubMed ID: 7053854
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An immunochemotherapeutic system for the treatment of a transplanted Moloney virus-induced lymphoma in mice.
    Glynn JP; Halpern BL; Fefer A
    Cancer Res; 1969 Mar; 29(3):515-20. PubMed ID: 4180092
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.